Human Papillomavirus (HPV) Testing for Normal Cervical Cytology in Low-Risk Women Aged 30-65 Years by Family Physicians

被引:3
|
作者
de la Cruz, Maria Syl D. [2 ]
Young, Alisa P. [1 ]
Ruffin, Mack T. [1 ]
机构
[1] Univ Michigan, Dept Family Med, Ann Arbor, MI 48104 USA
[2] Thomas Jefferson Univ, Dept Family & Community Med, Philadelphia, PA 19107 USA
基金
美国国家卫生研究院;
关键词
Diagnostic Use; Human Papilloma Virus DNA Probes; Mass Screening; Vaginal Smears; SCREENING PRACTICES; CANCER; US;
D O I
10.3122/jabfm.2013.06.120260
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Purpose: The purpose of this study was to assess ordering of human papillomavirus (HPV) testing for normal cervical cytology among low-risk women aged 30 to 65 years. Methods: Audits of 833 cytology request forms for low-risk women completing a Papanicolaou smear, from January 2008 to April 2011, from 5 Michigan family medicine clinics determined HPV orders completed by the clinician performing the Papanicolaou smear. Multivariate logistic regression models examined differences in HPV test ordering by patient age at Papanicolaou test, provider status and sex, and clinic across sites. A Poisson regression model analyzed the annual number of HPV test orders over time. Results: Cytology requests were completed by 622 faculty (75%), 169 residents/fellows (20%), and 42 nurse practitioner/physician assistants (NP/PAs) (5%). HPV testing for any cytology result was ordered on 324 request forms (39%) by residents/fellows (48%), faculty (38%), and NP/PAs (10%). Female providers were twice as likely as men to order HPV testing for any cytology result across all clinics and provider statuses (P < .001). There were significant differences in HPV test ordering among clinics. Between 2008 and 2011 annual cytology requests increased 46%, including HPV testing for any cytology result after adjusting for faculty provider sex. Conclusion: HPV test ordering when cytology is collected varied by clinic and provider status and sex. HPV co-testing for any cytology result remains modest, but is increasing over time in these clinics.
引用
收藏
页码:720 / 727
页数:8
相关论文
共 34 条
  • [31] Head-to-Head Comparison of the RNA-Based Aptima Human Papillomavirus (HPV) Assay and the DNA-Based Hybrid Capture 2 HPV Test in a Routine Screening Population of Women Aged 30 to 60 Years in Germany
    Iftner, Thomas
    Becker, Sven
    Neis, Klaus-Joachim
    Castanon, Alejandra
    Iftner, Angelika
    Holz, Barbara
    Staebler, Annette
    Henes, Melanie
    Rall, Katharina
    Haedicke, Juliane
    von Weyhern, Claus Hann
    Clad, Andreas
    Brucker, Sara
    Sasieni, Peter
    JOURNAL OF CLINICAL MICROBIOLOGY, 2015, 53 (08) : 2509 - 2516
  • [32] Long-term risk of cervical intraepithelial neoplasia grade 3 or worse according to high-risk human papillomavirus genotype and semi-quantitative viral load among 33,288 women with normal cervical cytology
    Thomsen, Louise T.
    Frederiksen, Kirsten
    Munk, Christian
    Junge, Jette
    Iftner, Thomas
    Kjaer, Susanne K.
    INTERNATIONAL JOURNAL OF CANCER, 2015, 137 (01) : 193 - 203
  • [33] Research on the cutoff tumor size of omitting radiotherapy for BCSS after breast conserving surgery in women aged 65 years or oder with low-risk invasive breast carcinoma: Results based on the SEER database
    Yang, Zejian
    Li, Kunlong
    Qiu, Pei
    Ma, Yifei
    Wang, Bin
    Yan, Yu
    Meng, Du
    Feng, Chen
    Ren, Yu
    Li, Yijun
    Li, Pingping
    Zhou, Can
    BREAST, 2021, 60 : 287 - 294
  • [34] High-risk human papillomavirus testing versus cytology in predicting post-treatment disease in women treated for high-grade cervical disease: A systematic review and meta-analysis
    Kocken, Marielle
    Uijterwaal, Margot H.
    de Vries, Anton L. M.
    Berkhof, Johannes
    Ket, Johannes C. F.
    Helmerhorst, Theo J. M.
    Meijer, Chris J. L. M.
    GYNECOLOGIC ONCOLOGY, 2012, 125 (02) : 500 - 507